DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) for Healthcare
How does DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) apply to healthcare?
Hospitals, pharmaceutical companies, medical device manufacturers, health insurers, and clinical research organisations face some of the strictest compliance requirements globally. DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) provides 16 controls across 4 domains that healthcare organisations map onto their sector obligations, so one control satisfies several requirements instead of being evidenced separately for each.
Why healthcare regulators care about DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190)
Hospitals, pharmaceutical companies, medical device manufacturers, health insurers, and clinical research organisations face some of the strictest compliance requirements globally. Patient data protection, clinical trial integrity, and medical device safety demand rigorous governance frameworks.
Healthcare organisations typically navigate HIPAA, FDA regulations, GxP requirements, and regional data protection laws simultaneously. A structured compliance framework helps consolidate these overlapping obligations into a manageable programme.
DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) provides 16 controls organised across 4 domains that can be mapped to healthcare-specific regulatory requirements. This structured approach helps organisations avoid compliance gaps while reducing the overhead of managing multiple overlapping obligations.
Where healthcare implementations of DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) get stuck
Healthcare organisations implementing DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) commonly face these challenges:
Protecting electronic health records (EHR) and patient data across distributed systems
Meeting multiple overlapping regulations (HIPAA, FDA 21 CFR, GxP, GDPR for clinical trials)
Securing connected medical devices and IoT endpoints in clinical environments
Managing third-party vendor risk across supply chains for pharmaceuticals and devices
Balancing rapid digital health innovation with data protection requirements
A working order for healthcare implementations
1. Assess Current State
Conduct a readiness assessment against DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) to identify gaps specific to your healthcare environment. Our AI-powered assessment takes 5 minutes and produces a prioritised action plan.
2. Map Regulatory Overlap
Use cross-framework mapping to identify where DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) controls satisfy other healthcare regulations. This reduces duplicate effort and accelerates compliance.
3. Implement Priority Controls
Focus on high-risk gaps first, using healthcare-specific threat intelligence to prioritise controls that address your most material risks.
4. Monitor & Improve
Establish continuous monitoring and regular reassessment cycles. Healthcare regulations evolve frequently, so compliance is an ongoing programme, not a one-time project.
Who owns DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) in a healthcare organisation
DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) in other sectors
Questions healthcare teams ask about DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190)
Why is DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) important for Healthcare?
How do Healthcare organisations implement DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190)?
What are the biggest DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) compliance challenges in Healthcare?
Does DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) satisfy Healthcare regulatory requirements?
How long does DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190) implementation take in Healthcare?
How ready is your Healthcare organisation for DORA RTS on Threat-Led Penetration Testing (Commission Delegated Regulation (EU) 2025/1190)?
Answer 25 questions and get a professional readiness report with gap analysis, maturity scores, and prioritised action items tailored to healthcare. Results in 5 minutes.